The pathogenic variants in KIF5A and MYH2 genes are associated with autosomal dominant conditions but not one (hereditary spastic paraplegia or body myopathy type 3) is clinically consistent with symptoms of the patient. This evidence concerns the gene MYH2 and hereditary spastic paraplegia.